Status: Recruiting
Neurocutaneous Melanocytosis Registry
This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanocytosis (NCM).
Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Sep 30, 2025Locations: 2Duration: 7 Years
Eligibility criteria
Dark-colored patch of skin present at birth [+7]
Informed consent has not been provided.